tyrosine has been researched along with Carcinoma, Papillary in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 13 (81.25) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, Y; Chen, YA; Dhillon, J; Fang, B; Fishman, M; Haake, SM; Haura, EB; Kinose, F; Koomen, JM; Li, J; Pow-Sang, JM; Rathmell, WK; Welsh, EA; Zent, R | 1 |
Hirokawa, M; Kodama, R; Miyauchi, A; Nakamura, Y; Sanke, T; Takamura, Y; Yasuoka, H | 1 |
Bai, XH; De Falco, V; Kapus, A; Liu, M; Lodyga, M; Melillo, RM; Santoro, M | 1 |
Dinauer, C; Fenton, C; Francis, GL; Patel, A; Powers, PA; Terrell, R; Tuttle, RM | 1 |
Chung, HK; Hemmings, BA; Hwang, ES; Hwang, IY; Hwang, JH; Kim, DW; Kim, H; Kim, JM; Park, J; Park, KC; Shong, M; Song, JH; Suh, JM | 1 |
Brockman, D; Fagin, JA; Kim, HW; Knauf, JA; Millhorn, DE; Mitsutake, N; Moretti, S; Myatt, L; Puxeddu, E; Seta, KA | 1 |
Basolo, F; Castellone, MD; Celetti, A; Cirafici, AM; Curcio, F; Fusco, A; Giannini, R; Guarino, V; Kruhoffer, M; Medico, E; Melillo, RM; Orntoft, TF; Santoro, M | 1 |
Chung, HK; Hwang, ES; Hwang, JH; Jung, HS; Kim, DW; Kim, JM; Park, KC; Park, SH; Park, YJ; Shong, M; Song, JH; Suh, JM; Yun, HJ | 1 |
Karihtala, P; Kinnula, VL; Soini, Y | 1 |
Chung, HK; Hwang, JH; Jo, KW; Jo, YS; Jung, HS; Kim, DW; Park, JS; Park, KC; Park, SH; Shong, M; Song, JH | 1 |
Kitahara, S; Matsubara, O; Murakawa, T; Tanabe, T; Tanimoto, T; Tsuda, H | 1 |
Kakudo, K; Miyauchi, A; Nakamura, M; Nakamura, Y; Takamura, Y; Yasuoka, H; Zuo, H | 1 |
Dinauer, CA; Fenton, C; Gary, FL; Nikiforov, YE; Patel, A; Ramirez, R; Tuttle, RM | 1 |
Alberti, L; Arighi, E; Borrello, MG; Ghizzoni, S; Gishizky, ML; Mercalli, E; Pierotti, MA; Radice, MT; Sangregorio, R | 1 |
Shimaoka, K; Volpert, EM | 1 |
Bongarzone, I; Borrello, MG; Della Porta, G; Fusco, A; Gambetta, RA; Grieco, M; Lanzi, C; Migliazza, A; Santoro, M; Zunino, F | 1 |
16 other study(ies) available for tyrosine and Carcinoma, Papillary
Article | Year |
---|---|
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Topics: Carcinoma, Papillary; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; ErbB Receptors; Extracellular Matrix; Humans; Kidney Neoplasms; Mass Spectrometry; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proteomics; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 2016 |
CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis.
Topics: Carcinoma, Papillary; Cell Line, Tumor; Chemokine CXCL12; Enzyme Inhibitors; Humans; Immunohistochemistry; Lymphatic Metastasis; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitroso Compounds; Receptors, CXCR4; RNA, Messenger; Thyroid Neoplasms; Tyrosine | 2008 |
XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Northern; Bromodeoxyuridine; Carcinoma, Papillary; Cell Proliferation; Flow Cytometry; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oncogene Proteins, Fusion; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrosine | 2009 |
Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Carcinoma, Papillary; Child; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Thyroid Neoplasms; Tyrosine | 2002 |
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Amino Acid Sequence; Animals; Carcinoma, Papillary; CHO Cells; Cricetinae; Enzyme Inhibitors; Fibroblasts; Humans; Mice; Molecular Sequence Data; Nuclear Receptor Coactivators; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Signal Transduction; src-Family Kinases; Thyroid Neoplasms; Transcription Factors; Transcriptional Activation; Tumor Suppressor Protein p53; Tyrosine | 2003 |
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway.
Topics: Animals; Blotting, Northern; Carcinoma, Papillary; Cell Line; Chromatography, High Pressure Liquid; Culture Media, Conditioned; Cyclooxygenase 2; Dinoprostone; Disease Progression; Dose-Response Relationship, Drug; Eicosanoids; Gene Library; Humans; Hydroxyeicosatetraenoic Acids; Intramolecular Oxidoreductases; Isoenzymes; Membrane Proteins; Mutation; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Rats; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Thyroid Neoplasms; Time Factors; Transcription, Genetic; Transcriptional Activation; Tyrosine; Up-Regulation | 2003 |
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
Topics: Carcinoma, Papillary; Cell Division; Cell Line, Tumor; Cell Transformation, Neoplastic; Collagen; Collagen Type I; DNA; Drug Combinations; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Laminin; Neoplasm Invasiveness; Osteopontin; Phenotype; Phosphorylation; Protein Structure, Tertiary; Proteoglycans; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Recombinant Proteins; Sialoglycoproteins; Signal Transduction; Thyroid Neoplasms; Tyrosine | 2004 |
Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
Topics: Carcinoma, Papillary; DNA-Binding Proteins; Genes, MHC Class II; HLA-DR Antigens; Humans; Interferon Regulatory Factor-1; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Nuclear Proteins; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphoproteins; Phosphorylation; Promoter Regions, Genetic; Protein Inhibitors of Activated STAT; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Signal Transduction; Small Ubiquitin-Related Modifier Proteins; STAT1 Transcription Factor; Thyroid Neoplasms; Trans-Activators; Transcriptional Activation; Tyrosine | 2004 |
Antioxidative response for nitric oxide production in breast carcinoma.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Papillary; Catalase; Female; Free Radical Scavengers; Humans; Middle Aged; Neoplasms, Ductal, Lobular, and Medullary; Nitric Oxide; Nitric Oxide Synthase; Oxidants; Oxidation-Reduction; Oxidative Stress; Protein Isoforms; Superoxide Dismutase; Tyrosine; Vascular Endothelial Growth Factor A | 2004 |
Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases.
Topics: Animals; Carcinoma, Papillary; Cells, Cultured; Cytoplasm; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Thyroid Gland; Thyroid Neoplasms; Tyrosine | 2005 |
Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
Topics: Antigens, Neoplasm; Carcinoma, Papillary; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Receptor, ErbB-2; RNA, Messenger; Thyroid Neoplasms; Tyrosine | 2005 |
Nitric oxide in papillary thyroid carcinoma: induction of vascular endothelial growth factor D and correlation with lymph node metastasis.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; RNA, Messenger; Thyroid Neoplasms; Tyrosine; Vascular Endothelial Growth Factor D | 2006 |
Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults.
Topics: Adolescent; Adult; Carcinoma, Papillary; Child; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphokines; Male; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Registries; Thyroid Neoplasms; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2000 |
Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Amino Acid Sequence; Amino Acid Substitution; Animals; Carcinoma, Papillary; Cell Line; Cell Transformation, Neoplastic; Chlorocebus aethiops; COS Cells; Drosophila Proteins; Humans; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Oncogenes; Protein Isoforms; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Recombinant Proteins; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; src Homology Domains; Thyroid Neoplasms; Transfection; Tyrosine | 2001 |
Iodoamino acids in abnormal and grossly normal thyroids: Comparison between 125I and 127I distribution.
Topics: Adenoma; Adult; Aged; Amino Acids; Carcinoma, Papillary; Cysts; Female; Goiter, Nodular; Humans; Iodine Isotopes; Iodine Radioisotopes; Isotope Labeling; Male; Middle Aged; Thyroid Diseases; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms; Thyroxine; Triiodothyronine; Tyrosine | 1977 |
Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Topics: 3T3 Cells; Animals; Blotting, Western; Carcinoma, Papillary; Drosophila Proteins; Gene Rearrangement; Humans; Mice; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Tetradecanoylphorbol Acetate; Thyroid Neoplasms; Tyrosine | 1992 |